Climb Bio, Inc. Common Stock
CLYM •
Buy Open
Signal type
Buy
Status
Open
Open Price
$3.25
Stop Loss
$2.92
Performance
172.31%
Days Open
124
Signal Setup
Signal Type Buy
Status Open
Open Date Dec 12, 2025
Open Price $3.25
Stop Loss $2.92
Timespan Day
Company Profile
Name Climb Bio, Inc. Common Stock
Ticker CLYM
Market Cap $83.79M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $8.85
List Date Aug 10, 2021
Description
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
Website Open Company Website